Cantor Fitzgerald Reiterates Overweight on Axogen, Maintains $12 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Ross Osborn has reiterated an Overweight rating on Axogen (NASDAQ:AXGN) and maintained a $12 price target for the company's stock.
January 19, 2024 | 2:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Ross Osborn reaffirmed an Overweight rating on Axogen with a steady price target of $12.
The reiteration of an Overweight rating and the maintenance of a $12 price target by a reputable analyst could instill confidence in investors and positively influence Axogen's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100